A Randomized, Controlled Trial of Intermittent Preventive Treatment with Sulfadoxine-Pyrimethamine, Amodiaquine, or the Combination in Pregnant Women in Ghana.


Clerk, CA; Bruce, J; Affipunguh, PK; Mensah, N; Hodgson, A; Greenwood, B; Chandramohan, D; (2008) A Randomized, Controlled Trial of Intermittent Preventive Treatment with Sulfadoxine-Pyrimethamine, Amodiaquine, or the Combination in Pregnant Women in Ghana. The Journal of infectious diseases, 198 (8). pp. 1202-11. ISSN 0022-1899 DOI: https://doi.org/10.1086/591944

Full text not available from this repository. (Request a copy)

Abstract

BACKGROUND: The use of sulfadoxine-pyrimethamine (SP) for intermittent preventive treatment in pregnancy (IPTp) is threatened by the spread of resistance to SP. Therefore, we studied the efficacy, safety, and tolerance of amodiaquine (AQ) or the combination of AQ and SP (SPAQ) as possible alternative treatments. METHODS: The study was performed in Ghana from June 2004 through February 2007. Women were individually randomized to receive IPTp with SP (n=1328), AQ (n= 986), or SPAQ (n=1328). Incidences of anemia, peripheral anemia, and placental parasitemia at delivery were assessed for paucigravidae, as were the birth weights of their infants. Delivery outcomes and the incidence of adverse events were investigated for all women. RESULTS: The prevalences of anemia (as defined by a hemoglobin concentration of <11.0 g/dL) at delivery were comparable between the SP and AQ groups and between the SP and SPAQ groups. Similarly, there was no significant difference between the SP and AQ groups or between the SP and SPAQ groups with regard to the incidences of low birth weight (LBW). Women who received AQ or SPAQ were more likely to report adverse events than were those who received SP. CONCLUSION: The effects of IPTp with AQ or SPAQ on maternal anemia and LBW were comparable to the effects of IPTp with SP; however, IPTp regimens that contain AQ are unlikely to be useful as an alternative to IPTp with SP in Ghana, because of a high frequency of associated adverse events. TRIAL REGISTRATION: Clinicaltrials.gov identifier: NCT00146783 .

Item Type: Article
Faculty and Department: Faculty of Infectious and Tropical Diseases > Dept of Disease Control
Research Centre: Malaria Centre
Centre for Maternal, Reproductive and Child Health (MARCH)
PubMed ID: 18752443
Web of Science ID: 259891800017
URI: http://researchonline.lshtm.ac.uk/id/eprint/7159

Statistics


Download activity - last 12 months
Downloads since deposit
0Downloads
319Hits
Accesses by country - last 12 months
Accesses by referrer - last 12 months
Impact and interest
Additional statistics for this record are available via IRStats2

Actions (login required)

Edit Item Edit Item